Another meta-analysis among 1112 cases and 1043 controls indicates that LPL Ser447Ter polymorphism is likely to be associated with a reduced risk of AD in the Northern-American population (OR = 0.56, 95% CI = 0.35–0.91, P = 0.02). The gene discussed is LPL; the disease is Alzheimer disease.